Price Alert

Tvardi Therapeutics Inc. (TVRD)

NASDAQ: TVRD · Real-Time Price · USD

24.30

0.51 (2.14%)

At close: Aug 15, 2025, 3:59 PM

24.00

-1.23%

After-hours: Aug 15, 2025, 04:10 PM EDT

Tvardi Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Net Income	-4.91M	-7.68M	-12.48M	-20.02M	-30.7M	-4.35M	-28.03M
Depreciation & Amortization	n/a	n/a	73K	77K	42K	24K	521K
Stock-Based Compensation	1.43M	n/a	n/a	n/a	3.35M	85K	n/a
Other Working Capital	-484K	1.85M	-2.97M	2.38M	-6.06M	-1.52M	1.87M
Other Non-Cash Items	94K	5.43M	8.98M	5.36M	1.74M	13K	3.23M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.31M	-1.79M	-10.56M	2.14M	-4.88M	-1.52M	4.63M
Operating Cash Flow	-4.69M	-4.04M	-13.98M	-12.44M	-30.45M	-5.75M	-19.64M
Capital Expenditures	n/a	n/a	n/a	-210K	-836K	n/a	-323K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	-32.21M	n/a	-22.85M
Sales Maturities Of Investments	n/a	5M	2.5M	15.5M	59M	n/a	46.33M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	5M	2.5M	15.29M	25.95M	n/a	23.16M
Debt Repayment	1.01M	-1.61M	-694K	-610K	-685K	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	1.01M	-1.61M	-694K	-610K	-685K	n/a	1.12M
Net Cash Flow	-3.69M	-658K	-10.68M	2.24M	-5.19M	-5.75M	4.63M
Free Cash Flow	-4.69M	-4.04M	-13.98M	-12.65M	-31.29M	-5.75M	-19.97M